A Risk-Adapted Strategy of Adjuvant Paclitaxel/Carboplatin in Early-Stage Ovarian Cancer: Time-Dependent Effect of 4 versus 6 Cycles on Outcome
Keyword(s):
2006 ◽
Vol 2006
◽
pp. 117-118
Keyword(s):
Keyword(s):
1985 ◽
Vol 147
(5)
◽
pp. 313
Keyword(s):